International Drug and Psychedelic Laws

Truffle Talks

2021 Psychedelic Investors Guide

American Psychedelic Renaissance

[stock_market_widget type="ticker-quotes" template="chart" color="blue" assets="MMED.NE,CYBN.NE,MMEDF,SHRMF,CMPS,NUMI.V,PLNT.CN,RVV.CN,LITT.V,WUHN,MCUR.CN,CODE.CN,MYCOF,TRMNF,LOBE.CN,TBI.CN,HAVN.CN,GBLC.CN,HOLL.CN,AION.CN" speed="75" direction="left" pause="true" api="yf" height="20px" ]

Psychedelic Science and Medicine Roundup: March 21-March 26

Share on facebook
Share on twitter
Share on linkedin
Share on email

With each passing week, we are seeing more and more advances in psychedelic research from the scientific and medical fields. As the body of research continues to grow, Truffle Report has compiled a roundup of major medical and scientific news from March 21 to March 26 2021, making it easier for you to track these ongoing developments.

Lab Expansion Project in Nanaimo to Aid Magic Mushroom, Psychedelics Research

March 21 , 2021 Numinus Wellness Inc., based in British Columbia, is expected to add a 7,500-square-foot addition to its existing complex by the end of 2021. This expansion will strengthen the facility’s research capacity.

New Research Could Help Predict Acute Reactions to Psychedelic Drugs

March 22, 2021 – New research from Ohio State University has identified personality traits that have been associated with positive and negative experiences on psychedelics in previous studies. This information could help predict how future patients will respond to the drugs.

Psychedelic Joint Venture Between Mycotopia Therapies and Natural MedTech Brings Research and Drug Development to Test Active Ingredient In Psychedelics

March 22, 2021 – Mycotopia Therapies, (OTC Pink: TWGL) (the “Company”), a Florida based company focused on psychedelic therapies, announced this week it has created PsyBioMed – Australia and that they have entered into a letter of intent to jointly conduct clinical trials in Australia using psychedelics to treat mental illnesses. This partnership intends to obtain licences and permits to legally possess, supply, sell, and manufacture psychedelics in Australia.

See Also
LSD Neutralizer Graphic

UW–Madison Pioneers Master’s Program in Therapeutic Use of Psychoactive Drugs

March 23, 2021 – The University of Wisconsin–Madison School of Pharmacy will enroll students in their new online MS in Pharmaceutical Sciences: Psychoactive Pharmaceutical Investigation this fall. This is the first and only master’s program of its kind in the United States. 

XPhyto Therapeutics Diversifies Into Psychedelics With New Labs

March 25, 2021 – XPhyto Therapeutics, a Vancouver based corporation, is currently expanding into psychedelic medicines by launching XPhyto Laboratories. The company’s focus involves the formulation of psychedelic compounds into mood-improving and therapeutic pharmaceutical drugs. XPhyto’s psychedelic research is led by German psychedelic researcher Professor Raimar Löbenberg.

#Psychedelic use is on the rise among college-age adults in the US. - @lucidnewssite

'Early 2020 saw psychedelic use among college-age young adults reach its highest levels since 1982, the culmination of a five-year upward trend.'

Great review on the impact of psychedelics on neuroplasticity from the team at Maastricht!

Why More Young Women Are Taking Shrooms

"...young women report taking shrooms recreationally and doing it predominantly to aid their mental health."

Load More...

Related Articles

Denver Psilocybin Reform Image

Denver Activists Want Psilocybin Sharing, Communal Use

Scroll To Top